Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy - 15/08/19
![](/templates/common/images/mail.png)
Abstract |
Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approximately 3.2% of the world's population. In this section of the guidelines of care for psoriasis, we will focus the discussion on ultraviolet (UV) light–based therapies, which include narrowband and broadband UVB, UVA in conjunction with photosensitizing agents, targeted UVB treatments such as with an excimer laser, and several other modalities and variations of these core phototherapies, including newer applications of pulsed dye lasers, intense pulse light, and light-emitting electrodes. We will provide an in-depth, evidence-based discussion of efficacy and safety for each treatment modality and provide recommendations and guidance for the use of these therapies alone or in conjunction with other topical and/or systemic psoriasis treatments.
Le texte complet de cet article est disponible en PDF.Key words : climatotherapy, Goeckerman, grenz ray, intense pulsed dye laser, narrowband ultraviolet light A (NB-UVA), narrowband ultraviolet light B (NB-UVB), photochemotherapy, photodynamic therapy, phototherapy, psoralen ultraviolet light A, psoriasis, pulsed dye laser, PUVA (topical, bath, oral), visible light
Abbreviations used : ALA, BB, BSA, FAE, IPL, MAL, MED, 8-MOP, MTX, NAPSI, NB, PASI, PASI 75, PASI 90, PDL, PDT, PpIX, PUVA, QoL, RCT, SAPASI, TMP, UV, UVA, UVB
Plan
Funding sources: None. |
|
Conflicts of interest: Listed in text. |
|
Reprints not available from the authors. |
Vol 81 - N° 3
P. 775-804 - septembre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?